Edwards Jonathan S. 4
4 · Phathom Pharmaceuticals, Inc. · Filed Oct 30, 2019
Insider Transaction Report
Form 4
Edwards Jonathan S.
Director
Transactions
- Conversion
Common Stock
2019-10-29$15.20/sh+23,558$358,082→ 23,558 total(indirect: By Medicxi Growth Co-Invest I LP) - Conversion
Convertible Promissory Notes
2019-10-29→ 0 total(indirect: By Medicxi Growth I LP)Exercise: $15.20Exp: 2020-05-07→ Common Stock (991,672 underlying) - Purchase
Common Stock
2019-10-29$19.00/sh+1,028,205$19,535,895→ 2,019,877 total(indirect: By Medicxi Growth I LP) - Conversion
Common Stock
2019-10-29$15.20/sh+991,672$15,073,414→ 991,672 total(indirect: By Medicxi Growth I LP) - Purchase
Common Stock
2019-10-29$19.00/sh+24,426$464,094→ 47,984 total(indirect: By Medicxi Growth Co-Invest I LP) - Conversion
Convertible Promissory Notes
2019-10-29→ 0 total(indirect: By Medicxi Growth Co-Invest I LP)Exercise: $15.20Exp: 2020-05-07→ Common Stock (23,558 underlying)
Footnotes (3)
- [F1]Immediately prior to the closing of the Issuer's initial public offering, the outstanding principal and unpaid accrued interest due on the Convertible Promissory Notes automatically converted into shares of the Issuer's Common Stock.
- [F2]Held by Medicxi Growth I LP ("Medicxi Growth I"). Medicxi Growth I GP Limited ("Medicxi Growth I GP") is the sole general partner of Medicxi Growth I, and Medicxi Ventures Management (Jersey) Limited ("Medicxi Manager") is the manager of Medicxi Growth I and Medicxi Growth Co-Invest I LP ("Medicxi Growth Co-Invest I"). The Reporting Person is a partner of an affiliate of Medicxi Manager. The Reporting Person disclaims Section 16 beneficial ownership of the securities held by Medicxi Growth I, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that he has beneficial ownership of such shares for Section 16 or any other purpose.
- [F3]Held by Medicxi Growth Co-Invest I. The Reporting Person disclaims Section 16 beneficial ownership of the securities held by Medicxi Growth Co-Invest I, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that he has beneficial ownership of such shares for Section 16 or any other purpose.